Anti-inflammatory and Antimicrobial Roles of Secretory Leukocyte Protease Inhibitor

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2005 Feb 26

PMID 15731023

Citations 92

Authors

Stergios Doumas

Alexandros Kolokotronis

Panagiotis Stefanopoulos

Affiliations

Soon will be listed here.

Citing Articles

A Novel Splice Variant Confers Susceptibility to Otitis Media in Humans.

Elling C, Ryan A, Yarza T, Ghaffar A, Llanes E, Kofonow J Int J Mol Sci. 2025; 26(4).

PMID: 40003878 PMC: 11855725. DOI: 10.3390/ijms26041411.

Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models.

Majumder S, Mishra S, Shinde N, Cuitino M, Bauer M, Ahirwar D Breast Cancer Res. 2025; 27(1):1.

PMID: 39754221 PMC: 11697808. DOI: 10.1186/s13058-024-01933-3.

Profiling endogenous airway proteases and antiproteases and modeling proteolytic activation of Influenza HA using in vitro and ex vivo human airway surface liquid samples.

Brocke S, Reidel B, Ehre C, Rebuli M, Robinette C, Schichlein K PLoS One. 2024; 19(12):e0306197.

PMID: 39739661 PMC: 11687774. DOI: 10.1371/journal.pone.0306197.

Secretory leukocyte protease inhibitor influences periarticular joint inflammation in -infected mice.

Qian Y, Yu Q, Xiaotian T, Tang X, Thomas H, Hart T bioRxiv. 2024; .

PMID: 39651186 PMC: 11623497. DOI: 10.1101/2024.11.24.625079.

Daikenchuto, a Japanese herbal medicine, ameliorates experimental colitis in a murine model by inducing secretory leukocyte protease inhibitor and modulating the gut microbiota.

Ozaka S, Sonoda A, Kudo Y, Ito K, Kamiyama N, Sachi N Front Immunol. 2024; 15:1457562.

PMID: 39524440 PMC: 11543465. DOI: 10.3389/fimmu.2024.1457562.

References

Zhang Y, Dewitt D, McNeely T, Wahl S, Wahl L . Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest. 1997; 99(5):894-900. PMC: 507897. DOI: 10.1172/JCI119254. View

Jin F, Nathan C, Radzioch D, Ding A . Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 1997; 88(3):417-26. DOI: 10.1016/s0092-8674(00)81880-2. View

Tomee J, Hiemstra P, Heinzel-Wieland R, Kauffman H . Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis. 1997; 176(3):740-7. DOI: 10.1086/514098. View

Naif H, Li S, Alali M, SLOANE A, Wu L, Kelly M . CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol. 1998; 72(1):830-6. PMC: 109444. DOI: 10.1128/JVI.72.1.830-836.1998. View

Wahl S, McNeely T, Janoff E, Shugars D, Worley P, Tucker C . Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis. 1997; 3 Suppl 1:S64-9. DOI: 10.1111/j.1601-0825.1997.tb00377.x. View

Shugars D, Sauls D, Weinberg J . Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. Oral Dis. 1997; 3 Suppl 1:S70-2. DOI: 10.1111/j.1601-0825.1997.tb00379.x. View

Tomee J, Koeter G, Hiemstra P, Kauffman H . Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?. Thorax. 1998; 53(2):114-6. PMC: 1758711. DOI: 10.1136/thx.53.2.114. View

Kikuchi T, Abe T, Hoshi S, Matsubara N, Tominaga Y, Satoh K . Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes. Am J Respir Cell Mol Biol. 1998; 19(6):875-80. DOI: 10.1165/ajrcmb.19.6.3314. View

Gipson T, Bless N, Shanley T, Crouch L, Bleavins M, Younkin E . Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol. 1999; 162(6):3653-62. View

10.

Shugars D . Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis. 1999; 179 Suppl 3:S431-5. DOI: 10.1086/314799. View

11.

Schalkwijk J, Wiedow O, Hirose S . The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J. 1999; 340 ( Pt 3):569-77. PMC: 1220286. View

12.

Konopka K, Shine N, Pretzer E, Duzgunes N . Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity. J Dent Res. 1999; 78(12):1773-6. DOI: 10.1177/00220345990780120201. View

13.

Nystrom M, Bergenfeldt M, Ljungcrantz I, Lindeheim A, Ohlsson K . Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells. Mediators Inflamm. 2000; 8(3):147-51. PMC: 1781797. DOI: 10.1080/09629359990478. View

14.

Hocini H, Becquart P, Bouhlal H, Adle-Biassette H, Kazatchkine M, Belec L . Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol. 2000; 7(3):515-8. PMC: 95905. DOI: 10.1128/CDLI.7.3.515-518.2000. View

15.

Ashcroft G, Lei K, Jin W, Longenecker G, Kulkarni A, Greenwell-Wild T . Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med. 2000; 6(10):1147-53. DOI: 10.1038/80489. View

16.

Pillay K, Coutsoudis A, Kuhn L, Coovadia H, Janoff E . Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 2001; 183(4):653-6. DOI: 10.1086/318535. View

17.

Simpson A, Wallace W, Marsden M, Govan J, Porteous D, Haslett C . Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J Immunol. 2001; 167(3):1778-86. DOI: 10.4049/jimmunol.167.3.1778. View

18.

Shugars D, WATKINS C, Cowen H . Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age. Gerontology. 2001; 47(5):246-53. DOI: 10.1159/000052808. View

19.

Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J . Novel distribution of the secretory leucocyte proteinase inhibitor in kidney. Mediators Inflamm. 2002; 10(6):347-50. PMC: 1781734. DOI: 10.1080/09629350120102389. View

20.

Westin U, Nystrom M, Ljungcrantz I, Eriksson B, Ohlsson K . The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm. 2002; 11(1):7-12. PMC: 1781642. DOI: 10.1080/09629350210304. View